CLAIM #3063 · Abbott Laboratories (ABT) · 2023Q2 earnings call · Jul 19, 2023 · due Dec 31, 2023
“So growth is doing very well... and I expect to see this continuing throughout this year.”
Robert Ford · CEO
PENDING
graded after results covering Dec 31, 2023 are reported
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2023Q2 earnings call.